A target role for mast cell in the prevention and therapy of hepatic fibrosis

Medical Hypotheses

Volumn 70, Issue 4, 2008, Pages 760-764

  Shen, Ding Zhu ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; CHYMASE; HISTAMINE; PROTEOGLYCAN; SILYMARIN; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; TRANILAST; TRYPTASE;

ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; DISEASE ASSOCIATION; DISEASE COURSE; DRUG ACTIVATION; DRUG MECHANISM; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIVER CIRRHOSIS; LIVER FIBROSIS; MAST CELL; MAST CELL DEGRANULATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; TREATMENT INDICATION;

ANIMALS; CELLS, CULTURED; FIBROSIS; HUMANS; IMMUNOGLOBULIN E; INFLAMMATION; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; MAST CELLS; MODELS, THEORETICAL; STEM CELL FACTOR;

EID: 39849095724     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.07.042     Document Type: Article

References (38)

1. Missale G., Ferrari C., and Fiaccadori F. Cytokine mediators in acute inflammation and chronic course of viral hepatitis. Ann Ital Med Int 10 1 (1995) 14-18
2. Border W.A., and Noble N.A. Transforming growth factor beta in tissue fibrosis. N Engl J Med 331 19 (1994) 1286-1292
3. Stoyanova I.I. Relevance of mast cells and hepatic lobule innervation to liver injury. Rom J Gastroenterol 13 3 (2004) 203-209
4. Akiyoshi H., and Terada T. Mast cell,myofibroblast and nerve terminal complexes in carbon tetrachloride-induced cirrhotic rat livers. J Hepatol 29 1 (1998) 112-119
5. Yamashiro M., Kouda W., Kono N., Tsuneyama K., Matsui O., and Nakanuma Y. Distribution of intrahepatic mast cells in various hepatobiliary disorders. An immunohistochemical study. Virchows Arch 433 5 (1998) 471-479
6. Schwartz L.B. Mast cells: function and contents. Curr Opin Immunol 6 1 (1994) 91-97
7. Schwartz L.B. Tryptase from human mast cells:biochemistry, biology and clinical utility. Monogr Allergy 27 (1990) 90-113
8. Schechter N.M. Human chymase. Monogr Allergy 27 (1990) 114-131
9. Oh C.K., and Metcalfe D.D. Transcriptional regulation of the TCA3 gene in mast cells after Fc epsilon RI cross-linking. J Immunol 153 1 (1994) 325-332
10. Alam R., Kumar D., Anderson-Walters D., and Forsythe P.A. Macrophage inflammatory protein-1 alpha and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo. J Immunol 152 3 (1994) 1298-1303
11. Smith T.J., Ducharme L.A., and Weis J.H. Preferential expression of interleukin-12 or interleukin-4 by murine bone marrow mast cells derived in mast cell growth factor or interleukin-3. Eur J Immunol 24 4 (1994) 822-826
12. Liu P., Liu C., Xu L.M., Hu Y.Y., Xue H.M., Liu C.H., and Zhang Z.Q. Effects of Fuzheng Huayu 319 recipe on liver fibrosis in chronic hepatitis B. World J Gastroenterol 4 4 (1998) 348-353
13. Bochner B.S., and Schleimer R.P. Mast cells, basophils, and eosinophils:distinct but overlapping pathways for recruitment. Immunol Rev 179 (2001) 5-15
14. Galli S.J. New concepts about the mast cell. N Engl J Med 328 4 (1993) 257-265
15. Galli S.J. New insights "the riddle of the mast cells": microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 62 1 (1990) 5-33
16. Murata K., Okudaira M., and Akashio K. Mast cells in human liver tissue Increased mast cell number in relation to the components of connective tissue in the cirrhotic process. Acta Derm Venereol Suppl (Stockh) 73 (1973) 157-165
17. Yoshikawa H., and Tasaka K. Suppression of mast cell activation by glucocorticoid. Arch Immunol Ther Exp (Warsz) 48 6 (2000) 487-495
18. Terada T., and Matsunaga Y. Increased mast cells in hepatocellular carcinoma and intrahepatic cholangicarcinoma. J Hepatol 33 6 (2000) 961-966
19. Satomura K., Yin M., Shimizu S., Kato Y., Nagano T., Komeichi H., et al. Increased chymase in livers with autoimmune disease:colocalization with fibrosis. J Nippon Med Sch 70 6 (2003) 490-495
20. Weber S., Kruger-Krasagakes S., Grabbe J., Zuberbier T., and Czarnetzki B.M. Mast cells. Int J Dermatol 34 1 (1995) 1-10
21. Armbrust T., Batusic D., Ringe B., and Ramadori G. Mast cells distribution in human liver disease and experimental rat liver fibrosis. Indications for mast cell participation in development of liver fibrosis. J Hepatol 26 5 (1997) 1042-1054
22. Farrell D.J., Hines J.E., Walls A.F., Kelly P.J., Bennett M.K., and Burt A.D. Intrahepatic mast cells in chronic liver diseases. Hepatology 22 4Pt1 (1995) 1175-1181
23. Sugihara A., Tsujimura T., Fujita Y., Nakata Y., and Terada N. Evaluation of role of mast cells in the development of liver fibrosis using mast cell-deficient rats and mice. J Hepatol 30 5 (1999) 859-867
24. Matsunaga Y., Kawasaki H., and Terada T. Stromal mast cells and nerve fibers in various chronic liver diseases:relevance to hepatic fibrosis. Am J Gastroenterol 94 7 (1999) 1923-1932
25. Matsunaga Y., and Terada T. Mast cell subpopulations in chronic inflammatory hepatobiliary diseases. Liver 20 2 (2000) 152-156
26. Enerback L., and Norrby K. The mast cells. Curr Top Pathol 79 (1989) 169-204
27. Feldman M.J., Morris G.P., Dinda P.K., and Paterson W.G. Mast cells mediate acid-induced augmentation of opossum esophageal blood flow via histamine and nitric oxide. Gastroenterology 110 1 (1996) 121-128
28. Qu Z., Liebler J.M., Powers M.R., Galey T., Ahmadi P., Huang X.N., et al. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol 147 3 (1995) 564-573
29. Jeong W.I., Lee C.S., Park S.J., Chung J.Y., and Jeong K.S. Kinetics of macrophages,myofibroblasts and mast cells in carbon tetrachloride-induced rat liver cirrhosis. Anticancer Res 22 2A (2002) 869-877
30. Metcalfe D.D., Baram D., and Mekori Y.A. Physiol Rev 77 4 (1997) 1033-1079
31. Galli S.J., Zsebo K.M., and Geissler E.N. The kit ligand,stem cell factor. Adv Immunol 55 (1994) 1-96
32. Yamamoto T., Katayama I., and Nishioka K. Role of mast cells in dermatofibroma:recent viewpoints into the pathogenesis. Eur J Dermatol 13 5 (2003) 419-423
33. Gruber B.L. Mast cells in the pathogenesis of fibrosis. Curr Rheumatol Rep 5 2 (2003) 147-153
34. Kinet J.P. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu Rev Immunol 17 (1999) 931-972
35. Friedman S.L., Maher J.J., and Bissell D.M. Mechanisms and therapy of hepatic fibrosis: report of the AASLD single topic basis research conference. Hepatology 32 6 (2000) 1403-1408
36. Wells R.G. The role of matrix stiffness in hepatic stellate cell activation and liver fibrosis. J Clin Gastroenterol 39 4 Suppl 2 (2005) S158-S161
37. Campbell J.S., Hughes S.D., Gilbertson D.G., Palmer T.E., Holdren M.S., Haran A.C., et al. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci USA 102 9 (2005) 3389-3394
38. Xiao Y.H., Liu D.W., and Li Q. Effects of drug serum of anti-fibrosis I herbal compound on calcium in hepatic stellate cell and its molecular mechanism. World J Gastroenterol 11 10 (2005) 1515-1520